145 related articles for article (PubMed ID: 10619218)
21. Quality of life and atypical antipsychotics.
Rudnick A
J Clin Psychopharmacol; 1998 Oct; 18(5):424-5. PubMed ID: 9790165
[No Abstract] [Full Text] [Related]
22. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
Conley RR; Mahmoud R
Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
[TBL] [Abstract][Full Text] [Related]
23. Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine.
Weiss EL; Longhurst JG; Bowers MB; Mazure CM
J Clin Psychopharmacol; 1999 Aug; 19(4):378-80. PubMed ID: 10440469
[No Abstract] [Full Text] [Related]
24. Early use of clozapine for poorly responding first-episode psychosis.
Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
[TBL] [Abstract][Full Text] [Related]
25. The promise of new drugs for schizophrenia treatment.
Tamminga CA
Can J Psychiatry; 1997 Apr; 42(3):265-73. PubMed ID: 9114942
[TBL] [Abstract][Full Text] [Related]
26. Weight gain associated with antipsychotic drugs.
Ganguli R
J Clin Psychiatry; 1999; 60 Suppl 21():20-4. PubMed ID: 10548138
[TBL] [Abstract][Full Text] [Related]
27. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Kapur S; Zipursky RB; Remington G
Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
[TBL] [Abstract][Full Text] [Related]
28. Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region.
Weissman EM
Schizophr Bull; 2002; 28(1):31-42. PubMed ID: 12047020
[TBL] [Abstract][Full Text] [Related]
29. Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone.
Dernovsek MZ; Tavcar R
Int Clin Psychopharmacol; 2000 Jul; 15(4):237-8. PubMed ID: 10954065
[TBL] [Abstract][Full Text] [Related]
30. The use of atypical antipsychotics in French psychiatric hospitals.
Bret MC; Bret P; Pariente A; Fourier-Réglat A
Pharm World Sci; 2007 Oct; 29(5):551-6. PubMed ID: 17638111
[TBL] [Abstract][Full Text] [Related]
31. Elevation of prolactin levels by atypical antipsychotics.
Turrone P; Kapur S; Seeman MV; Flint AJ
Am J Psychiatry; 2002 Jan; 159(1):133-5. PubMed ID: 11772702
[TBL] [Abstract][Full Text] [Related]
32. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
[TBL] [Abstract][Full Text] [Related]
33. Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine.
Chengappa KN; Pollock BG; Parepally H; Levine J; Kirshner MA; Brar JS; Zoretich RA
J Clin Psychopharmacol; 2000 Jun; 20(3):311-6. PubMed ID: 10831017
[TBL] [Abstract][Full Text] [Related]
34. Combined use of risperidone and olanzapine in the treatment of patients with resistant schizophrenia: a preliminary case series report.
Lerner V; Chudakova B; Kravets S; Polyakova I
Clin Neuropharmacol; 2000; 23(5):284-6. PubMed ID: 11154098
[TBL] [Abstract][Full Text] [Related]
35. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Casey DE; Daniel DG; Wassef AA; Tracy KA; Wozniak P; Sommerville KW
Neuropsychopharmacology; 2003 Jan; 28(1):182-92. PubMed ID: 12496955
[TBL] [Abstract][Full Text] [Related]
36. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R
Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293
[TBL] [Abstract][Full Text] [Related]
37. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
38. Novel antipsychotics: comparison of weight gain liabilities.
Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
[TBL] [Abstract][Full Text] [Related]
39. Atypical antipsychotic drugs and long-term outcome in schizophrenia.
Weiden P; Aquila R; Standard J
J Clin Psychiatry; 1996; 57 Suppl 11():53-60. PubMed ID: 8941171
[TBL] [Abstract][Full Text] [Related]
40. Experience with the atypical antipsychotics--risperidone and olanzapine in the elderly.
Madhusoodanan S; Suresh P; Brenner R; Pillai R
Ann Clin Psychiatry; 1999 Sep; 11(3):113-8. PubMed ID: 10482120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
